期刊文献+

应用M13引物PCR指纹法分析假丝酵母菌氟康唑耐药性 被引量:1

Fluconazole resistance in Candida albicans assayed by PCR fingerprinting with M13 primer
下载PDF
导出
摘要 目的探讨M13微卫星引物PCR指纹法用于假丝酵母菌氟康唑耐药性基因分型的可行性。方法采用纸片扩散法分析假丝酵母菌氟康唑耐药性,并进一步对41株假丝酵母菌进行M13引物PCR指纹分析,采用RAPD200软件邻接法(neighbour joining,NJ)聚类分析电泳带型模式。结果41例主要从痰液和阴道分泌物中分离的假丝酵母菌标本中中,氟康唑药物敏感11株(26.8%),依赖8例(19.5%),耐药22例(53.7%),PCR指纹分析至少可检测到12种不同的条带,条带数目从2条到12条不等,电泳带型模式与感染部位和氟康唑药物反应性有关。结论假丝酵母菌氟康唑耐药性菌珠所占比例较大,M13微卫星引物PCR指纹法可用于假丝酵母菌的分子流行病学调查和氟康唑耐药性基因分型。 Objective TounderstandthemolecularandgeneticmechanismunderlyingfluconazoleresistanceinCandida albicans by PCR fingerprinting with M13 primer. Methods Paper disc diffusion method was employed for assay of fluconazoleresistance in 41 clinical isolates of Candida albicans, followed by PCR fingerprinting with M13 primer to study the gel patternswith cluster analysis using neighbor joining (NJ) method performed with RAPD200 software. Results Of the 41 clinicalisolates, 11 strains (26.8%) were fluconazole-sensitive, 8 (19.5%) fluconazole-dependent and 22 (53.7%) flucona-zole-resistance. Two to twelve bands could be observed among these strains, and the gel patterns revealed by cluster analysiswere associated with the reactions of the strains against fluconazole and the location of infection. Conclusion There is highprevalence of fuconazole resistance in clinical Candida albicans isolates, and PCR fingerprinting with M13 primer is con-venient for assay of fuconazole resistance and molecular epidemiological study of Candida albicans.
出处 《第一军医大学学报》 CSCD 北大核心 2003年第12期1303-1306,共4页 Journal of First Military Medical University
关键词 PCR指纹法 假丝酵母菌 氟康唑 耐药性 纸片扩散法 M13微卫星引物 抗真菌药物 Candida albicans PCR fingerprinting fuconazole drug resistance
  • 相关文献

参考文献8

  • 1[1]Bossche HV, Marichal P, Odds FC. Molecular mechanisms of drug resistance in fungi[J]. Trends Microbiol, 1994, 2: 393-400.
  • 2[2]Bossche HV. Mechanisms ofantifungal resistance[J]. Rev Iberoam Micol, 1997, 14(1): 44-9.
  • 3[3]Pfaller MA, Lockhart SR, Pujol C, et al. Hospital specificity, region specificity, and fluconazole resistance of candida albicans bloodstream isolates[J]. J Clin Microbiol, 1998, 36(6): 1518-29.
  • 4[4]Tamura M, Watanabe K, Mikami Y, et al. Molecular characterization of new clinical isolates of Candida albicans and C.dubliniensis in japan: analysis reveals a new genotype of C. albicans with group iintron[ J ]. J Clin Microbiol, 2001, 39: 4309-15.
  • 5[5]McCullough MJ, Clemons KV, Stevens DA. Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea [ J ].J Clin Microbiol, 1997, 37: 417-21.
  • 6[6]National committee for clinical laboratory standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts.Approved standard M27-A. National committee for clinical laboratory standards, Wayne, Pa.
  • 7[7]Imai T, Watanabe K, Tamura YM, et al. Geographic grouping of Cryptococcus neoformans var. gattii by random amplified polymorphic DNA fingerprint patterns and its sequence divergence [ J ]. Clin Lab,2000, 46(7-8): 345-54.
  • 8[8]Franz R, Kelly SL, Lamb DC, et al. Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical candida albicans strains[J]. Antimicrob Agents Chemother,1998, 42: 3065-72.

同被引文献12

  • 1Loeffler J, Hagmeyer L, Hebart H, et al. Rapid detection of point mutations by fluorescence resonance energy transfer and probe melting curves in Candida species [J]. Clin Chem, 2000, 46(5):631-5.
  • 2White TC, Holleman S, Dy F, et ol. Resistance mechanisms in clinical isolates of Candida albicans [J]. Antimicrob Agents Chemother,2002, 46(6): 1704-13.
  • 3Peters S, Koschinsky S, Schwieger F, et ol. Succession of microbial communities during hot composting as detected by PCR-singlestrand-conformation polymorphism-based genetic profiles of small-subunit rRNA genes [J ]. Appl Environ Microbiol, 2000, 66(3): 930-6.
  • 4Perea S, Lopez-Ribot JL, Kirkpatriek WR, et al. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Condida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients [J].Antimicrob Agents Chemother, 2001, 45( 10): 2676-84.
  • 5Aoyama Y, Kudo M, Asai K, et al. Emergence of fluconazoleresistant sterol 14-demethylase P450 (CYP51) in Candida albicans is a model demonstrating the diversification mechanism of P450 [J].Arch Biochem Biophys, 2000, 379(1): 170-1.
  • 6Walsh TJ, Francesconi A, Kasai M, et ol. PCR and single-strand conformational polymorphism for recognition of medically important opportunistic fungi [ J ]. J Clin Microbiol, 1995, 33(12): 3216-20.
  • 7Sanglard D, Ischer F, Koymans L, et ol. Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51AI)from azole-resistant Condida 01bicans clinical isolates contribute to resistance to azole antifungalagents[J ]. Antimicrob Agents Chemother,1998, 42(2): 241-53.
  • 8Song JL, Harry JB, Eastman RT, et ol. The Candida 01bicans lanosterol 14-alpha-demethylase (ERG 11) gene promoter is maximally induced after prolonged growth with antifungal drugs [J].Antimicrob Agents Chemother, 2004, 48(4): 1136-44.
  • 9Mart KA, Lyons CN, Rustad TR, et ol. Rapid, transient fluconazole resistance in Condida 01bicans is associated with increased mRNA levels of CDR[J]. Antimicrob Agents Chemother, 1998, 42(10):2584-9.
  • 10Barker KS, Crisp S, Wiederhold N, et al. Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicons [J]. J Antimicrob Chemother, 2004, 54(2): 376-85.

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部